stars 1 stars 2 stars 3

Kaléo is a global leader in drug-delivery device technology and auto-injector innovation, helping provide millions of patients and emergency responders with security and peace of mind. Our patented Aerio™ platform, with unmatched capabilities and human factor engineering, powers our portfolio of auto-injectors products, as well as products under development with third parties. Visit us at Kaleo.com to learn more.

Website http://www.kaleo.com
Revenue $73.9 million
Funding $165 million
Employees 109 (87 on RocketReach)
Founded 2005
Address 111 Virginia St, Richmond, Virginia 23219, US
Phone +1 804-545-6360
Technologies
Industry Pharmaceuticals, Pharmaceutical Manufacturing, Healthcare, Drug Delivery, Medical Devices, Human Factors Engineering (HFE), Biotechnology
Competitors Pfizer, Sanofi, Novo Nordisk, AstraZeneca, Bristol Myers Squibb, Amgen, Boehringer Ingelheim, Teva Pharmaceuticals, Lilly India, Mylan Belgium +43 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies

Kaléo Questions

The Kaléo annual revenue was $73.9 million in 2026.

George Parise is the CFO of Kaléo.

87 people are employed at Kaléo.

Kaléo is based in Richmond, Virginia.

The NAICS codes for Kaléo are [325, 32, 3254, 32541].

The SIC codes for Kaléo are [283, 28].

Top Kaléo Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users